Header and Body 3

Technology

This invention comprises monoclonal antibody pairs that can identify Zika virus infection at high specificity. The target antigen is the NS1 glycoprotein. This invention includes a paperfluidic detection kit able to detect Zika virus infections in under 30 minutes and minimal input sample. Tissue extracts, bodily fluids, blood or derivatives or blood are suitable for diagnostic applications.